Michael H. Kagey - Concepedia

Author

Michael H. Kagey

Angeles Clinic and Research Institute ORCID

Also Known As

Kagey, Michael H., M Kagey, M. Kagey, M.H. Kagey, Michael H Kagey, Michael H. Kagey, Michael Kagey, Michael H. Kagey

Publications

8.4K

Citations

H-Index

Concepts

All Affiliations

Angeles Clinic and Research Institute University of Virginia Duke Medical Center Dana-Farber Cancer Institute Whitehead Institute for Biomedical Research

About

Michael H. Kagey is an author at Angeles Clinic and Research Institute specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	6.8K
2	Cell Biology	4	4	5.3K
3	Immunology	3	3	42
4	Health Sciences	2	2	509
5	Gastroenterology	2	2	25

Michael H. Kagey

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes Warren A. Whyte, David A. Orlando, Denes Hnisz, Cell Transcriptional RegulationDevelopmental BiologyCell RegulationTranscription RegulationGene Regulation	2013	4.2K
Mediator and cohesin connect gene expression and chromatin architecture Michael H. Kagey, Jamie J. Newman, Steve Bilodeau, Nature ChromatinChromatin RemodelingGeneticsNuclear OrganizationGene Expression	2010	1.9K
The Polycomb Protein Pc2 Is a SUMO E3 Michael H. Kagey, Tiffany A. Melhuish, David Wotton Cell Polycomb Protein Pc2Protein FunctionMolecular BiologyProtein GeneticsCell Biology	2003	569
Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells Megan F. Cole, Sarah E. Johnstone, Jamie J. Newman, Genes & Development Embryonic StemCell SpecializationCanonical Wnt PathwayEs CellsStem Cells	2008	497
SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state Steve Bilodeau, Michael H. Kagey, Garrett M. Frampton, Genes & Development	2009	349
A Role for Non-Covalent SUMO Interaction Motifs in Pc2/CBX4 E3 Activity Jacqueline C. Merrill, Tiffany A. Melhuish, Michael H. Kagey, PLoS ONE	2010	81
Multiple activities contribute to Pc2 E3 function Michael H. Kagey, Tiffany A. Melhuish, Shannon Powers, The EMBO Journal Signal TransductionAction MonitoringMultiple ActivitiesHuman-computer InteractionNeuroscience	2004	73
mDKN-01, a Novel Anti-DKK1 mAb, Enhances Innate Immune Responses in the Tumor Microenvironment Michael Haas, Michael H. Kagey, Heidi Heath, Molecular Cancer Research	2020	68
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer David R. Wise, Jeffrey A. Schneider, Joshua Armenia, JCO Precision Oncology	2020	59
Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer Lipika Goyal, Cynthia A. Sirard, Michael Schrag, Clinical Cancer Research	2020	54

Page 1